Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action Farhy LS; McCall ALJ Diabetes Sci Technol 2010[Nov]; 4 (6): 1345-56This review analyzes an interdisciplinary approach to the pancreatic endocrine network-like relationships that control glucagon secretion and glucagon counterregulation (GCR). Using in silico studies, we show that a pancreatic feedback network that brings together several explicit interactions between islet peptides and blood glucose reproduces the normal GCR axis and explains its impairment in diabetes. An alpha-cell auto-feedback loop drives glucagon pulsatility and mediates triggering of GCR by hypoglycemia by a rapid switch-off of beta-cell signals. The auto-feedback explains the enhancement of defective GCR in beta-cell deficiency by a switch-off of signals in the pancreas that suppress alpha cells. Our models also predict that reduced beta-cell activity decreases and delays the GCR. A key application of our models is the in silico simulation and testing of possible scenarios to repair defective GCR in beta-cell deficiency. In particular, we predict that partial suppression of hyperglucagonemia may repair the impaired GCR. We also outline how the models can be extended and tested using human data to become a part of a larger construct including the regulation of the hepatic glucose output by the pancreas, circulating glucose, and incretins. In conclusion, a model of the normal GCR control mechanisms and their dysregulation in insulin-deficient diabetes is proposed and partially validated. The model components are clinically measurable, which permits its application to the study of the abnormalities of the human endocrine pancreas and their role in the progression of many diseases, including diabetes, metabolic syndrome, polycystic ovary syndrome, and others. It may also be used to examine therapeutic responses.|*Models, Biological[MESH]|*Systems Biology[MESH]|Animals[MESH]|Blood Glucose/*metabolism[MESH]|Computer Simulation[MESH]|Diabetes Mellitus/metabolism/physiopathology[MESH]|Feedback, Physiological[MESH]|Glucagon-Secreting Cells/*metabolism[MESH]|Glucagon/*metabolism[MESH]|Humans[MESH]|Hypoglycemia/metabolism/physiopathology[MESH]|Insulin-Secreting Cells/metabolism[MESH]|Insulin/metabolism[MESH]|Liver/metabolism[MESH]|Reproducibility of Results[MESH] |
